Experts say Moderna hasn't released enough information to properly assess early COVID-19 vaccine trial results
Moderna reports positive Phase 1 coronavirus vaccine data; Antibodies were detected in all participants after 2 vaccine injections. If successful, targeting early 2021 launch.
